The Cannabis Biotech Complex will produce cannabis tissue cultured plantlets utilizing the proprietary, "Chibafreen Invitro Plant Production System," allowing more tissue cultured plantlets to be produced in less space and less time. This is accomplished primarily by the 3-stage proprietary process developed by Dr. Afreen, Pharmagreen Biotech Inc's. Chief Operations Officer. In his article, , Ethan Reyes writes about a company in the TC space that utilizes the old four-stage TC propagation process. He does a decent job explaining in general terms, how TC works, however there is not a great deal of information as to the level of the technology used by the featured company. For a thorough explanation of the Chibafreen System, see the video at . In his article, Ethan Reyes offers one explanation for late adoption of TC, "Khurram Malik, CEO of , said he believes the cannabis sector's slow adoption of TC reveals persistent cultural attitudes towards innovation."
The service of tissue culture propagation offered by the Cannabis Biotech Complex, will include the provision of growing protocols (growing schedules) customized to the specific strains of large-scale clients. As Alliance has explained before, the cost of tissue culture plantlets is offset, by the elimination of the mother room and the lower risk of clones that are contaminated. In his article, , Blake Medulan provides further confirmation that utilizing TC micro-propagation will not only get a grower a superior beginning product, but it will also create additional production space. Mr. Medlan writes - Anandia CEO and co-founder Jonathan Page suggests, "The mothers take up a lot of space and there is a lot of horticultural work required to keep it going," he says, explaining "that is space that could be turned into production space."
Dennis Petke, President and CEO of Alliance Growers, commented. "We have spent over two years creating awareness about the value of TC for cannabis growing in general, and about the superiority of the "Chibafreen Invitro Plant Production System", specifically. It is very refreshing to begin seeing articles popping up everywhere regarding this much-needed service in the cannabis and hemp space." Dennis Petke continues "This increased awareness is timed perfectly with Alliance's newly acquired $4m financing facility, which is being drawn down in tranches at progressively higher prices, thus avoiding excessive dilution to its shareholders. Alliance has executed on the Term Sheet and Engagement Letter, the full announcement of which will be Friday or Monday, immediately following the closing of the initial 2m units of our recently announced Private-Placement. Alliance would like to thank its many supporters for staying with us, the rewards of which, are about to come to fruition."
About Alliance Growers Corp.
Alliance Growers is a Diversified Global Medical Cannabis Company driven by the Company's 'Four Pillars' Organization Plan - Cannabis Biotech Complex, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Technology.
Alliance Growers is working with Pharmagreen Biotech Inc. advancing a new business partnership, to jointly develop and operate a 63,000-square foot facility, to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general.
For further information, please visit the Company's website at or the Company's profile at .
If you would like to be added to Alliance Growers' news distribution list, please send your email address to .
On behalf of the board of directors of
ALLIANCE GROWERS CORP.
"Dennis Petke"
Dennis Petke
President and CEO
For more information contact:
Dennis Petke
Tel: 778-331-4266
Rob Grace
Corporate Communications
Tel: 778-998-5431
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company's corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company's ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company's ability to identify and complete additional suitable acquisitions to further the Company's growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
To view the source version of this press release, please visit
